PLIN5 and fatty liver disease: Wolins’ group reported that transgenic mice with PLIN5 overexpression in skeletal muscle display increased glucose tolerance and resistance to hepatic steatosis, which they attributed to increased serum levels of FGF21 (ref. 50).